GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration

NCT03739268 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sevelamer
DRUG: Placebo

Sponsor

Steno Diabetes Center Copenhagen

Collaborators

[object Object]